Answers are grounded in this paper and cite their sources.
This randomized trial evaluates a novel 3D printed scaffold for bone regeneration, suggesting its potential in tissue engineering.
In this study, a novel HPMC/gelatin composite scaffold was prepared by incorporating 13-93B3 borate bioactive glass (BBG) microparticles and cerium oxide (CeO₂) submicrometric particles as a discrete phase, enabling higher ceria loadings without disrupting the bioactive glass chemistry. Composite hydrogel inks containing 5 wt% BBG microparticles and up to 20 wt% CeO₂ submicrometric particles were successfully extrusion-printed into porous scaffolds with interconnected pore architecture. CeO₂ incorporation preserved printability and mechanical strength while significantly enhancing scaffold deformation ability. Degradation behavior was tunable, with BBG microparticles reducing swelling and CeO₂ submicrometric particles modulating water uptake and pH evolution. BBG microparticles and CeO₂ submicrometric particles synergistically promoted apatite formation following 7 days of SBF incubation. In vitro studies using MC3T3-E1 pre-osteoblasts confirmed high cytocompatibility and Alizarin red study showed enhanced mineralization in CeO₂-containing scaffolds. Additionally, BBG and CeO₂ incorporated scaffolds exhibited strong antibacterial activity against Staphylococcus aureus and Escherichia coli. Overall, this multifunctional scaffold platform demonstrates promise for bone tissue engineering applications.
No takes yet. Share an insight, caveat, or question.
İyigün et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: